相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An Update on Natural Occurrence and Biological Activity of Chromones
S. K. Sharma et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Design, Synthesis, and Biological Evaluation of Chromone-Based p38 MAP Kinase Inhibitors
Christine Dyrager et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways
Ji-Nan Dai et al.
PLOS ONE (2011)
VEGF Promotes the Transcription of the Human PRL-3 Gene in HUVEC through Transcription Factor MEF2C
Jianliang Xu et al.
PLOS ONE (2011)
Carbon Monoxide Induced PPARγ SUMOylation and UCP2 Block Inflammatory Gene Expression in Macrophages
Arvand Haschemi et al.
PLOS ONE (2011)
Synthesis of a novel series of diphenolic chromone derivatives as inhibitors of NO production in LPS-activated RAW264.7 macrophages
Guo-Biao Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Kinase inhibitors: a new approach to rheumatoid arthritis treatment
Stanley Cohen et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Mast Cell Stabilization Improves Survival by Preventing Apoptosis in Sepsis
Laura Ramos et al.
JOURNAL OF IMMUNOLOGY (2010)
The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Keith L. Kirkwood et al.
CURRENT DRUG METABOLISM (2009)
An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells
Lu Wang et al.
MOLECULAR PHARMACOLOGY (2009)
Phosphatase of Regenerating Liver-3 Localizes to Cyto-Membrane and Is Required for B16F1 Melanoma Cell Metastasis In Vitro and In Vivo
Ran Song et al.
PLOS ONE (2009)
Discovery and development of Toll-like receptor 4 (TLR4) antagonists: A new paradigm for treating sepsis and other diseases
Carlos G. Leon et al.
PHARMACEUTICAL RESEARCH (2008)
A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1
Wei Li et al.
PLOS ONE (2007)
p38 pathway kinases as anti-inflammatory drug targets
J. F. Schindler et al.
JOURNAL OF DENTAL RESEARCH (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity
A Matsuzawa et al.
NATURE IMMUNOLOGY (2005)
The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages
FM Ho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling
H Takatsuna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway
M Funakoshi-Tago et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression
HY Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
H Nishitoh et al.
GENES & DEVELOPMENT (2002)
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia
J Branger et al.
JOURNAL OF IMMUNOLOGY (2002)
Drosophila innate immunity: an evolutionary perspective
JA Hoffmann et al.
NATURE IMMUNOLOGY (2002)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Toll-like receptors control activation of adaptive immune responses
M Schnare et al.
NATURE IMMUNOLOGY (2001)
Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation
AS Kristof et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of TNF expression by multiple mitogen-activated protein kinase pathways
W Zhu et al.
JOURNAL OF IMMUNOLOGY (2000)